ALMR
Alamar Biosciences, Inc.Company with tickers: ALMR
CIK
2104204
CUSIP
010911105
Shares Outstanding
69,311,186
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $26,035,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | $11,578,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Gross Profit | $14,457,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Expenses | $26,804,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $13,017,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-12,347,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-21,325,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-1.74 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-1.74 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |